Related Experiment Video
Updated: May 27, 2025

Using Enzyme-based Biosensors to Measure Tonic and Phasic Glutamate in Alzheimer's Mouse Models
Published on: May 3, 2017
Enhanced Alzheimer's biomarker detection using a ternary composite electrochemical aptasensor
Zelong Fan1, Lingling Yuan1, Tingcheng Xia2
1School of Chemistry and Chemical Engineering, University of Jinan, Jinan, 250022, China.
A novel electrochemical aptasensor using graphene, metallic oxides, and conducting polymers offers highly sensitive detection of Alzheimer
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Electrochemistry
Background:
- Alzheimer's disease (AD) diagnosis requires sensitive and specific detection methods.
- Existing methods face limitations in sensitivity and specificity for early AD detection.
- Aβ1-40 oligomers are key biomarkers for early Alzheimer's disease diagnosis.
Purpose of the Study:
- To develop a highly sensitive electrochemical aptasensor for early Alzheimer's disease diagnosis.
- To overcome the limitations of current diagnostic tools for AD.
- To create a versatile biosensor platform for detecting specific biomarkers.
Main Methods:
- Fabrication of a ternary composite sensor using polypyrrole (PPy), reduced graphene oxide (rGO), and Fe₂O₃ nanoparticles.
- Utilizing aptamers as biorecognition elements for Aβ1-40 oligomer detection.
- Employing electrochemical techniques (CV, DPV, EIS) for sensor characterization and performance evaluation.
Main Results:
- Achieved an ultra-low detection limit of 40 fM for Aβ1-40 oligomers.
- Demonstrated a broad linear detection range from 0.1 pM to 200 nM.
- Exhibited exceptional sensitivity, selectivity, reproducibility, and stability in artificial serum samples.
Conclusions:
- The developed aptasensor shows significant potential for early Alzheimer's disease diagnosis and monitoring.
- The sensor's robust and modular design allows for adaptation to detect other target biomolecules.
- This advancement offers a versatile and highly sensitive tool for biomedical diagnostics and personalized medicine.
More Related Videos
15:23Selection of Aptamers for Amyloid β-Protein, the Causative Agent of Alzheimer's Disease
Published on: May 13, 2010
07:08A High Throughput, Multiplexed and Targeted Proteomic CSF Assay to Quantify Neurodegenerative Biomarkers and Apolipoprotein E Isoforms Status
Published on: October 20, 2016